Hanqing Xie

As the senior most position within the organization, Dr. Pace is responsible for helping to set the direction of the Center, including the establishment of near-term and long-term strategic and operating plans in partnership with the Executive Committee and founders of the Center.

He is an experienced biotech/pharmaceutical industry scientist with more than 25 years’ experience spanning pathogenesis research, and antibiotic and vaccine R&D. He has led efforts that resulted in the evaluation of 14 clinical candidates, and the approved antibiotic drugs AvyCaz, Altabax/Altargo, and Vibativ the latter of which he is also co-inventor.

He has worked for anti-infective companies on both coasts, as well as in France and Denmark, and is an Adjunct Associate Professor with the Biomanufacturing Research Institute and Technology Enterprise-North Carolina Central University.